Company Filing History:
Years Active: 2023
Title: Urbain Alfons C Delaet: Innovator in HIV Treatment Formulations
Introduction
Urbain Alfons C Delaet is a notable inventor based in Balen, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for HIV. His work has been recognized for its impact on improving patient outcomes through innovative formulations.
Latest Patents
Delaet holds a patent for "Darunavir combination formulations." This invention relates to solid oral dosage forms of the HIV inhibitor Darunavir and/or a pharmaceutically acceptable salt or solvate thereof, along with combination formulations thereof. His patent represents a crucial advancement in the treatment of HIV, providing new options for patients.
Career Highlights
Delaet is currently associated with Janssen Sciences Ireland UC, where he continues to work on innovative pharmaceutical solutions. His expertise in drug formulation has positioned him as a key player in the development of effective HIV treatments.
Collaborations
Throughout his career, Delaet has collaborated with esteemed colleagues, including Philip Erna H Heyns and Eugeen Maria Jozef Jans. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic options.
Conclusion
Urbain Alfons C Delaet's contributions to HIV treatment through his innovative formulations highlight the importance of research and collaboration in the pharmaceutical industry. His work continues to pave the way for advancements in patient care and treatment efficacy.